Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants

NCT07039929 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic Business Decision

Conditions

Healthy Participants

Interventions

DRUG: INCB000631
DRUG: Placebo

Sponsor

Incyte Corporation